^
BIOMARKER:
HR positive
i
Other names: ESR1, Era, ESR, NR3A1, ER, ER beta, PGR, Progesterone receptor, Nuclear receptor subfamily 3 group C member 3, NR3C3
Entrez ID:
HR positive
HER2 Negative Breast Cancer
ribociclib
Sensitive
:
A1
ESMO-BC 2021 - 1wk
HR positive
HER2 Negative Breast Cancer
abemaciclib
Sensitive
:
A1
ESMO-BC 2021 - 1wk
HR positive
HER2 Negative Breast Cancer
eribulin mesylate
Sensitive
:
C2
ESMO-BC 2021 - 1wk
HR positive
HER2 Negative Breast Cancer
palbociclib
Sensitive
:
A1
Cancer Invest - 3wk
HR positive
HER2 Positive Breast Cancer
neratinib
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
ribociclib
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
everolimus
Sensitive
:
A1
HR positive
HER2 Positive Breast Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
olaparib
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
letrozole
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
anastrozole
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
talazoparib
Sensitive
:
A1
HR positive
Hormone Receptor Positive Breast Cancer
fulvestrant
Sensitive
:
A1
HR positive
HER2 Negative Breast Cancer
fulvestrant
Sensitive
:
A1
HR positive
HER2 Positive Breast Cancer
trastuzumab
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
lapatinib
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
toremifene
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
HER2 inhibitor
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
HER2 inhibitor + Aromatase inhibitor
Sensitive
:
A2
HR positive
Male Breast Cancer
Aromatase inhibitor
Sensitive
:
A2
HR positive
Male Breast Cancer
tamoxifen
Sensitive
:
A2
HR positive
Hormone Receptor Positive Breast Cancer
palbociclib
Resistant
:
A2
HR positive
HER2 Negative Breast Cancer
Aromatase inhibitor
Sensitive
:
A2
HR positive
Hormone Receptor Positive Breast Cancer
everolimus
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
fulvestrant
Sensitive
:
A2
HR positive
HER2 Negative Breast Cancer
letrozole
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
trastuzumab + lapatinib
Sensitive
:
A2
HR positive
HER2 Positive Breast Cancer
Aromatase inhibitor
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our